This study investigates pancreatic adenocarcinoma. It will compare two imaging methods to see which one better assesses how patients respond to treatment before surgery.

The study evaluates the effectiveness of traditional CT scans and 3D-MSP technology in providing accurate preoperative images. It will measure how well each method works by comparing their results to surgical and histopathological outcomes.

• Who can participate: Adults with borderline or locally advanced pancreatic adenocarcinoma who have completed neoadjuvant treatment and plan to undergo surgery can participate. A preoperative CT scan is required.
• Study details: Participants will undergo imaging using both traditional CT and 3D-MSP technology before surgery. The study compares these imaging results to surgical outcomes to determine each method's accuracy.
• Study timelines: The study will last one year.